http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
김봉석 ( Kim Bong Seog ),김승진 ( Kim Seung Jin ),정윤수 ( Jeong Yun Su ),임성운 ( Im Seong Un ),노철균 ( No Cheol Gyun ),원철호 ( Won Cheol Ho ),조진호 ( Jo Jin Ho ),이건일 ( Lee Geon Il ) 한국센서학회 2003 센서학회지 Vol.12 No.3
본 연구에서는 택배물의 분류를 위한 자동화 시스템에서 주소 영역 검출 알고리즘을 제안하였다. 주소 영역 검출을 위한 알고리즘에서는 대상 영상이 매우 크기 때문에 수행 시간의 단축을 위하여 택배 라벨부분을 포함하는 제한된 범위인 관심영역(Region of interesting: ROI)을 구한 후 관심 영역내에서 모든 알고리즘이 수행되도록 한다. 주소 영역 검출을 위하여 택배 라벨의 특징인 주소 영역을 둘러싸고 있는 테두리선을 이용한다. 이진화(thresholding) 과정과 라벨링 (Labeling) 과정을 통하여 획득된 영상에서 주소 영역의 테두리선과 그 밖의 성분들을 각각 독립된 연결성분들(connected components)로 검출한다. 주소 영역을 둘러싸는 테두리선의 기하학적인 특징을 이용하여 여러 개의 연결성분들 중에서 주소 영역을 둘러싸는 테두리선을 분리한다. 마지막으로 윈 영상과 분리된 테두리선 부분과의 논리적 곱을 이용하여 주소 영역을 최종적으로 검출하게 된다. In this paper, we proposed the algorithm for locating destination address block (DAB) from automatic system to classify packages. For locating DAB, because the size of obtained images is are very large, we select the region of interesting (ROI) to reduce time carrying into algorithm. After selecting the ROI, proposed algorithm is carried out within the ROI. We extract the outline of the handwriting part of the DAB and the rest components within the obtained ROI using thresholding. We carry out labeling to extract each connected component for extracted outline and the rest components. We extract the outline of the handwriting part of the DAB using the geometrical characteristic of the outline of the handwriting part of the DAB among many connected components. The last, we extract the locating DAB using the outline of the handwriting part of the DAB.
김봉석(Bong Seog Kim),김서운(Seo Woon Kim),이영현(Young Hyun Lee),조희준(Hee Jun Cho),이춘택(Choon Taek Lee),도영수(Young Soo Do),김효윤(Hyo Youn Kim),조재일(Jae Ill Zo),심영목(Young Mog Shim),이진오(JIn Oh Lee),강태웅(Tae Woong Kang 대한내과학회 1994 대한내과학회지 Vol.46 No.4
N/A Objective: For curative surgical treatment of esophageal cancer the resectability from the tracheobrochial tree would be the most important factor. Although CT scan has been used for the determination of the resectability of esophageal cancer, it has a limitation on the detection of esophageal cancer invasion to tracheobronchial tree We have performed flexible bronchoscopy in the patients with esophageal cancer to detect and classify the tracheobronchial tree alterations and to find the relation of bronchoscopic findings with the resectability. Method: From April 1990 to October 1992, 133 patients with esophageal cancer had received bronchoscopy. Bronchoscopic findings were classified into three groups: [Group I: normal, Group II: indirect effects (hyperemia and compression-mild, moderate, severe), group III: invasion). CT findings were a]so classified into three classes: [Class A: tumor separated from tracheobronehial tree, Class B: abutting tree, Class C: compressing tree]. We investigated the resectability of esophageal cancer according to bronchoscopic and CT findings. Results: 1) Among 133 patients, the bronchscopic findings were Group I in 41(30.8%), Group II in 66(49.6%), and Group III in 26(19.6%) patients. 2) Abnormal bronchoscopic findings were mainly found in trachea and left main bronchus and frequently found in upper and middle esophageal cancer patients, 3) The resection rate from tracheobronchial tree was 96.8% in group I and 75% in group II bronchoscopic finding. 4) The resections from tracheobronchial tree could be performed in 94.6% of Class A, in 70% of Class B and in 53.8% of Class C of CT scan patients. 5) Six of twelve unresectable patients belonged to Class C of CT scan finding If we excluded Class C in Group II patients, resectability would be increased to 87.5%. Conclusion: We could recommend the operation in esophgeal cancer patients with Group I and minimal Group II bronchoscopic finding. In advanced Group II and/or Class C of CT scan patients, neoadjuvant treatment and reevaluation could be recommended.
진성다혈구증에 병발한 미세변화신증을 동반한 IgA 신병증
정영종 ( Young Jong Jung ),김범 ( Beom Kim ),조영미 ( Yong Mee Cho ),김희섭 ( Hee Sup Kim ),김지호 ( Ji Ho Kim ),김수연 ( Soo Yeun Kim ),김봉석 ( Bong Seog Kim ),최윤미 ( Youn Mi Choi ),문경협 ( Kyoung Hyoub Moon ) 대한신장학회 2008 Kidney Research and Clinical Practice Vol.27 No.6
Polycythemia vera is a hematopoietic stem cell disease, characterized by sustained and excessive proliferation of erythrocytic, granurocytic and megakaryocytic cells in the bone marrow resulting in pancytosis in peripheral blood. There have been a few reports of glomerulonephritis with polycythemia vera, most of which were IgA nephropathy. We report a case of a polycythemia vera associated with proteinuria. We confirmed the polycythemia vera according to World Health Organization criteria. Renal pathology showed IgA nephropathy and minimal change disease. Periodic phlebotomy was done and hydroxyurea was administered without specific managements for renal disease. After 3-month treatment, hemoglobin level decreased and proteinurea disappeared.
정태영,최영민,김봉석,이동우,김민숙,박준현,Jeong, Tae-Yeong,Choi, Young-Min,Kim, Bong-Seog,Lee, Dong-Woo,Gim, Min-Sook,Park, Jun-Hyun 대한생물정신의학회 2012 생물정신의학 Vol.19 No.2
Objectives : The purpose of this study was to examine the changes in metabolic parameters and Positive and Negative Syndrome Scale (PANSS) scores of patients previously treated with atypical antipsychotic drugs other than paliperidone, after 8 weeks of treatment with paliperidone. Methods : Changes in body weight, body mass index, leptin, lipid levels, fasting glucose, and PANSS scores of patients who switched from other atypical antipsychotic drugs to paliperidone were measured after 8 weeks of treatment with paliperidone. We compared these results with those of patients who had not been treated with antipsychotic drugs for at least 2 weeks prior to treatment with paliperidone (antipsychotic drug-free patients). Results : The antipsychotic drug-free group (n = 9) did not show significant changes in metabolic parameters, but showed a significant improvement in total and subscale scores of PANSS. In the group that switched from other atypical antipsychotic drugs to paliperidone (n = 13), body weight, body mass index and fasting glucose level significantly increased, while total and subscale scores of PANSS significantly improved. Conclusions : Paliperidone treatment will benefit patients with schizophrenia who have been antipsychotic drug-free or who have had difficulty with other atypical antipsychotic drugs, with regard to their psychopathological state. However, if patients have been treated with other atypical antipsychotic drugs before switching to paliperidone, they could gain body weight or their fasting glucose level could increase over a short period because of a change in receptor number and sensitivity caused by the previously prescribed antipsychotic drugs, and hence, paliperidone should be prescribed with caution for these patients.
REAL 분류상 B-미만성 대세포 림프종에서 조직학적 아형 분류의 임상적 의의
류민희 ( Min Hee Ryu ),김봉석 ( Bong Seog Kim ),김태원 ( Tae Won Kim ),박연희 ( Yeon Hee Park ),허주령 ( Joo Ryung Huh ),이승숙 ( Seung Sook Lee ),김철우 ( Chul Woo Kim ),류백렬 ( Baek Yeol Ryoo ),김노경 ( Noe Kyeong Kim ),이규형 대한내과학회 2003 대한내과학회지 Vol.65 No.1
목적 : REAL 분류상 B-미만성 대세포 림프종은 다양한 임상경과를 보이는 이질적인 림프종을 포함하고 있는데, 일부 연구에서는 B-미만성 대세포 림프종 중immunoblastic lymphoma (IBL)가 다른 조직아형에 비해 예후가 좋지 않음을 시사하고 있다. 본 연구에서는 B-미만성 대세포 림프종을 형태학적으로 IBL과 non-IBL로 세분화할 필요가 있는지 알아보고자 하였다. 방법 : 1989년부터 1995년까지 3개 병원에서 치료 받은 비호지 Background : Diffuse large B-cell lymphoma (DLBL) category in the REAL classification includes histologically heterogeneous subtypes in Working Formulation or Kiel classification. Some investigators insist that the prognosis of B-cell immunoblastic lympho
황인철 ( Hwang In Cheol ),김봉석 ( Kim Bong Seog ),김종수 ( Kim Jong Su ),선우재근 ( Seonu Jae Geun ),배동한 ( Bae Dong Han ),김현철 ( Kim Hyeon Cheol ) 대한산부인과학회 2003 Obstetrics & Gynecology Science Vol.46 No.11
Liver hematomas, infarction and ruptures complicated with preeclampsia are fatal to pregnant woman and fetus. So, close observation and proper diagnosis are demanded for treatment. Although the incidence of HELLP syndrome in severe preeclampsia and eclamp
진행성 위암에 대한 1차 요법으로 Docetaxel과 Cisplatin 복합화학요법의 효과와 안정성에 대한 연구
김경중 ( Gyung Jung Kim ),이세동 ( Sehe Dong Lee ),박종원 ( Jong Won Park ),신철호 ( Cheol Ho Sin ),황승재 ( Seung Jae Hwang ),남승현 ( Seung Hyun Nam ),김봉석 ( Bong Seog Kim ) 대한내과학회 2007 대한내과학회지 Vol.72 No.6
본 연구에서는 수술 후 재발한 진행성 또는 절제 불가능한 전이성 위암을 가진 42명의 환자를 대상으로 1차 항암요법으로 docetaxel과 cisplatin을 투여하여 높은 반응률과 감내할만한 부작용을 확인할 수 있었다. 향후 많은 환자를 대상으로 한 전향적 연구와 표적치료제를 포함한 병용치료에 대한 연구가 필요할 것으로 판단된다. Background: To evaluate the activity and safety of docetaxel and cisplatin for advanced gastric cancer as a first-line chemotherapy treatment. Methods: Between December 2001 and February 2006, forty-two patients with recurrent or metastatic gastric cancer were enrolled. Docetaxel (75 mg/m2) was administered as a 1-hour intravenous infusion on day 1 and cisplatin (60 mg/m2) was also administered as a 30-minute intravenous infusion on day 1 every three weeks until disease progression or severe toxicity was detected. The response was assessed every 2 cycles. The toxicities were evaluated for every course of chemotherapy according to NCI toxicity criteria. Results: The median age of the patients was 66 (range, 33~77) years. Among the forty-two patients, 38 were male. Twenty-seven patients had an Eastern Cooperative Oncology Group performance score of 0 or 1 and fifteen patients had a score of 2. All patients had adenocarcinoma. Thirty-three of the forty-two patients were assessable for response. Partial responses were observed in 14 patients. The overall response rate was 42.4% (95% C.I., 25.259.6%) and the median response duration was 5.7 (range, 1.4~17.2) months. The median overall survival of all patients was 8.1 (range, 1.2~47.0) months. During a total of 170 cycles, granulocytopenia worse than National Cancer Institute toxicity grade 3 occurred in 7.6% of the patients, thrombocytopenia in 0.6% and anemia in 3.5%, respectively. No deaths resulting from toxicity were observed. Non-hematologic toxicities were minor and were easily controlled. Conclusion: Combination chemotherapy with docetaxel and cisplatin has a tolerable efficacy with acceptable toxicities in patients with advanced gastric cancer as a first-line treatment. (Korean J Med 72:593-599, 2007)